RobotReviewer

RobotReviewer is a free, open-source tool for extracting PICO details and likely bias assessments from clinical-trial PDFs. It is best suited to systematic reviewers who need a repeatable website or API workflow and can handle technical deployment. Its analytical focus is useful, but its demanding setup makes it a poor match for anyone seeking a ready-to-use review workspace.

Overview

RobotReviewer applies the Cochrane Risk of Bias tool while identifying Population, Intervention, Comparator and Outcome characteristics in trial papers. Upload a PDF through its website to extract key data and view a summary table; use the REST API to work with groups of reports and synthesize results across trials. That makes it more compelling for recurring evidence workflows than for occasional checks of a single paper.

The project is licensed under the GNU GPL version 3.0 and can run locally as Docker services, with a web app and API server exposed on local ports. Local deployment offers control without subscription fees, but it also leaves installation and service management to the user.

Key features

• PICO and bias annotations: Automated extraction and likely bias assessments can help reviewers organize clinical-trial evidence. These outputs support evidence appraisal; they should not replace a reviewer’s judgment.
• PDF summaries: Website uploads yield extracted key data and a summary table, giving users a way to inspect individual reports without building an API workflow.
• Multi-report API: The REST API supports groups of clinical-trial reports, making it the stronger option for repeatable or larger-scale analysis. Endpoint code is in the project’s app.py.
• Deployment options: Docker services support local operation, with instructions for GPU use as well as CPU-only workers. That flexibility helps technically equipped users, though neither route removes the setup burden.
• Research use: RobotReviewer supports AI paper summaries, full-text analysis and systematic reviews. The maintainers ask users to cite the 2017 ACL paper when using the project.

Pricing

Free — free. The free plan is open source under GPL-3.0, with no subscription charge. It is the natural fit for individual researchers and teams able to run and maintain the software themselves. The trade-off is operational rather than a paid-plan feature gap: the documented manual setup calls for Python 3.6, TensorFlow 1.12.0, Grobid, RabbitMQ, Celery and SciBERT services.

RobotReviewer is not a low-friction hosted workspace for users who want someone else to manage those components. For questions or help incorporating it into other software, the project invites users to email [email protected].

Platforms

RobotReviewer is available through the web, API, Linux and macOS, with self-hosting supported. Installation is documented as tested on Ubuntu and Mac OS; Windows is possible but comes with substantial installation difficulty. Windows users who cannot manage that friction should consider another tool or deployment environment.

Who it's for

Choose RobotReviewer if your work centers on clinical-trial reports, you need PICO extraction and likely risk-of-bias assessments, and you can manage a technical installation or integrate an API. It is especially relevant to systematic-review workflows that process report groups. Look elsewhere if you need an immediately usable team workspace, do not want to administer multiple services, or depend on a straightforward Windows install.

Pros and cons

Pros

• No licensing fees: The GPL-3.0 project is free to use, which suits researchers who can supply their own infrastructure.
• Purpose-built trial analysis: PICO extraction and likely Cochrane Risk of Bias assessments target clinical-trial evidence rather than general paper reading.
• Website and API workflows: Users can summarize PDFs individually or process report groups through the API.
• Local execution choices: Docker, GPU instructions and CPU-only worker guidance give self-hosters deployment options.

Cons

• Substantial installation stack: Manual setup spans several services and specified legacy-era software components, creating real work before analysis begins.
• Windows friction: Installation is described as substantially difficult on Windows, making other platforms the safer choice for self-hosting.
• Specialized scope: Its stated focus is clinical-trial PDFs and trial-report synthesis, so it is not the obvious choice for broader literature-review needs.

Alternatives

For a wider comparison, browse AI Literature Review Software.

• Universal SLR Assistant is another free, open-source option for Linux, macOS, Windows and web users; choose it if its MIT-licensed approach better fits your workflow, noting that cloud AI provider API fees may apply.
• ASReview is free and open source across API, Linux, macOS, self-hosted, web and Windows. Consider it if you want a systematic-review alternative, while accounting for possible hardware or server costs when running it yourself.
• Rayyan offers web, Android, iOS and API access. Its free tier is capped at 3 active reviews, 2 free reviewers and 1 sample, with limited mobile access; choose it if those limits suit your review workflow.
• Elicit is a web and API alternative with a free Basic plan offering unlimited search across more than 138 million papers, summaries and chat with papers, alongside limited Research Agent and Research Reports usage. Choose it for that paper-search and chat workflow rather than RobotReviewer’s trial-focused annotation.
• Axelium has a free tier limited to one lifetime review and one seat, alongside a paid Researcher plan. It may suit a researcher who prefers its browser-extension or web workflow.
• Silvi offers a free Basic plan with unlimited reviews, screening and data extraction, plus a paid Rapid plan. It is an alternative for web-based review work.
• SWIFT-Review is free desktop software for macOS and Windows, made by Sciome LLC, a research and technology consulting company providing informatics solutions for life sciences researchers.
• Systematicly has a free Explorer tier with 3 active personal drafts, one lifetime feasibility preview and three lifetime Evidence Answers, along with manual drafting and browsing. Consider it if that drafting-oriented web workflow fits your needs.

Verdict

RobotReviewer is a strong fit for systematic reviewers focused on clinical-trial PDFs who want free PICO and likely bias analysis, multi-report API support and control over local deployment. Its main reason to choose is that specialized capability without licensing fees; its main reason to look elsewhere is the technical burden of installing and maintaining the required stack.